Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Conceptus (CPTS) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (84)	4/19/2008 11:07:39 AM
From: telephonics	Read Replies (1) \| Respond to of 96

Did you notice the cash or cash equivalents reported. $331 million???? What a performance. To get the company much needed publicity, management should either declare a shareholder dividend or a substantial stock buy back. The medical profession around the world is well aware that MRSA has an FDA approved treatment, but the health article writers don't seem to recognize that. Or perhaps, making that fact known to their readers tends to lessen the horror story they are trying to paint.